1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Bupivacaine Hydrochloride Injection Market, By Concentration
5.1 Introduction
5.2 0.25%
5.3 0.50%
5.4 0.75%
5.5 Other Concentrations
6 Global Bupivacaine Hydrochloride Injection Market, By Volume
6.1 Introduction
6.2 Small Volume (5 ML)
6.3 Medium Volume (10 ML)
6.4 Large Volume (>20 ML)
7 Global Bupivacaine Hydrochloride Injection Market, By Packaging
7.1 Introduction
7.2 Single-Dose Vials
7.3 Multi-Dose Vials
7.4 Ampoules
8 Global Bupivacaine Hydrochloride Injection Market, By Application
8.1 Introduction
8.2 Surgical Anesthesia
8.3 Obstetric Anesthesia
8.4 Chronic Pain Management
8.5 Orthopedic Procedures
8.6 Cardiovascular Procedures
8.7 Neurological Procedures
8.8 Dental Procedures
8.9 Other Applications
9 Global Bupivacaine Hydrochloride Injection Market, By End User
9.1 Introduction
9.2 Ambulatory Surgical Centers (ASCs)
9.3 Hospitals & Clinics
9.4 Specialty Clinics & Pain Management Centers
9.5 Dental Clinics
9.6 Other End Users
10 Global Bupivacaine Hydrochloride Injection Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Hikma Pharmaceuticals
12.2 Pfizer Inc.
12.3 Fresenius Kabi AG
12.4 Baxter International Inc.
12.5 AstraZeneca
12.6 AuroMedics Pharma LLC
12.7 Areva
12.8 SteriMax Inc.
12.9 Shanghai Harvest Pharmaceutical Co.
12.10 Southwest Pharma
12.11 Hunan Kelun Pharmaceutical
12.12 Aurobindo pharma
12.13 Sagent Pharmaceuticals
List of Tables
Table 1 Global Bupivacaine Hydrochloride Injection Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Bupivacaine Hydrochloride Injection Market Outlook, Concentration (2021-2030) ($MN)
Table 3 Global Bupivacaine Hydrochloride Injection Market Outlook, 0.25% (2021-2030) ($MN)
Table 4 Global Bupivacaine Hydrochloride Injection Market Outlook, 0.50% (2021-2030) ($MN)
Table 5 Global Bupivacaine Hydrochloride Injection Market Outlook, 0.75% (2021-2030) ($MN)
Table 6 Global Bupivacaine Hydrochloride Injection Market Outlook, Other Concentrations (2021-2030) ($MN)
Table 7 Global Bupivacaine Hydrochloride Injection Market Outlook, Volume (2021-2030) ($MN)
Table 8 Global Bupivacaine Hydrochloride Injection Market Outlook, Small Volume (5 ML) (2021-2030) ($MN)
Table 9 Global Bupivacaine Hydrochloride Injection Market Outlook, Medium Volume (10 ML) (2021-2030) ($MN)
Table 10 Global Bupivacaine Hydrochloride Injection Market Outlook, Large Volume (>20 ML) (2021-2030) ($MN)
Table 11 Global Bupivacaine Hydrochloride Injection Market Outlook, Packaging (2021-2030) ($MN)
Table 12 Global Bupivacaine Hydrochloride Injection Market Outlook, Single-Dose Vials (2021-2030) ($MN)
Table 13 Global Bupivacaine Hydrochloride Injection Market Outlook, Multi-Dose Vials (2021-2030) ($MN)
Table 14 Global Bupivacaine Hydrochloride Injection Market Outlook, Ampoules (2021-2030) ($MN)
Table 15 Global Bupivacaine Hydrochloride Injection Market Outlook, Application (2021-2030) ($MN)
Table 16 Global Bupivacaine Hydrochloride Injection Market Outlook, Surgical Anesthesia (2021-2030) ($MN)
Table 17 Global Bupivacaine Hydrochloride Injection Market Outlook, Obstetric Anesthesia (2021-2030) ($MN)
Table 18 Global Bupivacaine Hydrochloride Injection Market Outlook, Chronic Pain Management (2021-2030) ($MN)
Table 19 Global Bupivacaine Hydrochloride Injection Market Outlook, Orthopedic Procedures (2021-2030) ($MN)
Table 20 Global Bupivacaine Hydrochloride Injection Market Outlook, Cardiovascular Procedures (2021-2030) ($MN)
Table 21 Global Bupivacaine Hydrochloride Injection Market Outlook, Neurological Procedures (2021-2030) ($MN)
Table 22 Global Bupivacaine Hydrochloride Injection Market Outlook, Dental Procedures (2021-2030) ($MN)
Table 23 Global Bupivacaine Hydrochloride Injection Market Outlook, Other Applications (2021-2030) ($MN)
Table 24 Global Bupivacaine Hydrochloride Injection Market Outlook, End User (2021-2030) ($MN)
Table 25 Global Bupivacaine Hydrochloride Injection Market Outlook, Ambulatory Surgical Centers (ASCs) (2021-2030) ($MN)
Table 26 Global Bupivacaine Hydrochloride Injection Market Outlook, Hospitals & Clinics (2021-2030) ($MN)
Table 27 Global Bupivacaine Hydrochloride Injection Market Outlook, Specialty Clinics & Pain Management Centers (2021-2030) ($MN)
Table 28 Global Bupivacaine Hydrochloride Injection Market Outlook, Dental Clinics (2021-2030) ($MN)
Table 29 Global Bupivacaine Hydrochloride Injection Market Outlook, Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
